ABSCI CORP Capital Expenditures
ABSCI CORP (ABSI) reported Capital Expenditures of $31.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-11
- ABSCI CORP payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $1.00K, a 99.55% decline year-over-year.
- ABSCI CORP payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $30.00K, a 20.00% increase year-over-year.
- ABSCI CORP payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was -$103.00K, a 547.83% decline year-over-year.
- ABSCI CORP payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $962.00K, a 1904.17% increase year-over-year.
- ABSCI CORP payments to acquire property, plant, and equipment for fiscal 2025 was $1.11M, a 174.01% increase from fiscal 2024.
- ABSCI CORP payments to acquire property, plant, and equipment for fiscal 2024 was $404.00K, a 53.02% decline from fiscal 2023.
- ABSCI CORP payments to acquire property, plant, and equipment for fiscal 2023 was $860.00K, a 94.68% decline from fiscal 2022.
- ABSCI CORP payments to acquire property, plant, and equipment for fiscal 2022 was $16.18M, a 57.49% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $31.00K 10-Q · filed 2026-08-11 | -$72.00K derived: sum of 3 quarters · filed 2026-08-11 | $890.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $30.00K 10-Q · filed 2026-05-07 | -$73.00K derived: sum of 2 quarters · filed 2026-05-07 | $889.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.11M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $859.00K derived: sum of 2 quarters · filed 2026-03-24 | $1.08M derived: sum of 3 quarters · filed 2026-08-11 | $1.11M 10-K · filed 2026-03-24 |
| 2025-09-30 | $962.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.19M derived: sum of 2 quarters · filed 2026-08-11 | $1.21M 10-Q · filed 2025-11-12 | $1.23M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $223.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $248.00K 10-Q · filed 2026-08-11 | $271.00K derived: sum of 3 quarters · filed 2026-08-11 | $319.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $25.00K 10-Q · filed 2026-05-07 | $48.00K derived: sum of 2 quarters · filed 2026-05-07 | $96.00K derived: sum of 3 quarters · filed 2026-05-07 | $429.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $71.00K derived: sum of 2 quarters · filed 2026-03-24 | $404.00K derived: sum of 3 quarters · filed 2026-03-24 | $404.00K 10-K · filed 2026-03-24 |
| 2024-09-30 | $48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $381.00K derived: sum of 2 quarters · filed 2025-11-12 | $381.00K 10-Q · filed 2025-11-12 | $398.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $333.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $333.00K 10-Q · filed 2025-08-12 | $350.00K derived: sum of 3 quarters · filed 2025-08-12 | $657.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-13 | $17.00K derived: sum of 2 quarters · filed 2025-05-13 | $324.00K derived: sum of 3 quarters · filed 2025-05-13 | $580.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $324.00K derived: sum of 2 quarters · filed 2025-03-18 | $580.00K derived: sum of 3 quarters · filed 2025-03-18 | $860.00K 10-K · filed 2025-03-18 |
| 2023-09-30 | $307.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $563.00K derived: sum of 2 quarters · filed 2024-11-12 | $843.00K 10-Q · filed 2024-11-12 | $1.40M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $256.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $536.00K 10-Q · filed 2024-08-14 | $1.10M derived: sum of 3 quarters · filed 2024-08-14 | $5.97M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $280.00K 10-Q · filed 2024-05-14 | $840.00K derived: sum of 2 quarters · filed 2024-05-14 | $5.71M derived: sum of 3 quarters · filed 2024-05-14 | $9.60M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $560.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $5.43M derived: sum of 2 quarters · filed 2024-03-21 | $9.32M derived: sum of 3 quarters · filed 2024-03-21 | $16.18M 10-K · filed 2024-03-21 |
| 2022-09-30 | $4.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $8.76M derived: sum of 2 quarters · filed 2023-11-14 | $15.62M 10-Q · filed 2023-11-14 | $23.93M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $3.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $10.74M 10-Q · filed 2023-08-14 | $19.06M derived: sum of 3 quarters · filed 2023-08-14 | $24.68M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $6.86M 10-Q · filed 2023-05-15 | $15.17M derived: sum of 2 quarters · filed 2023-05-15 | $20.79M derived: sum of 3 quarters · filed 2023-05-15 | $38.54M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $8.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $13.94M derived: sum of 2 quarters · filed 2023-03-30 | $31.68M derived: sum of 3 quarters · filed 2023-03-30 | $38.05M 10-K · filed 2023-03-30 |
| 2021-09-30 | $5.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $23.37M derived: sum of 2 quarters · filed 2022-11-09 | $29.73M 10-Q · filed 2022-11-09 | $30.65M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $17.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $24.11M 10-Q · filed 2022-08-11 | $25.03M derived: sum of 3 quarters · filed 2022-08-11 | $25.77M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $6.36M 10-Q · filed 2022-05-11 | $7.28M derived: sum of 2 quarters · filed 2022-05-11 | $8.02M derived: sum of 3 quarters · filed 2022-05-11 | |
| 2020-12-31 | $920.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $1.66M derived: sum of 2 quarters · filed 2022-03-22 | $2.18M 10-K · filed 2022-03-22 | |
| 2020-09-30 | $735.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.26M 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $526.00K 10-Q · filed 2021-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |